Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RCKT

Rocket Pharmaceuticals (RCKT)

Rocket Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RCKT
DateTimeSourceHeadlineSymbolCompany
02/04/202421:00Business WireRocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi AnemiaNASDAQ:RCKTRocket Pharmaceuticals Inc
27/03/202407:01Business WireRocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership TeamNASDAQ:RCKTRocket Pharmaceuticals Inc
05/03/202410:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
05/03/202410:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
01/03/202407:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
01/03/202406:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
27/02/202408:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RCKTRocket Pharmaceuticals Inc
27/02/202408:01Business WireRocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent ProgressNASDAQ:RCKTRocket Pharmaceuticals Inc
22/02/202412:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
22/02/202412:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
22/02/202412:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
22/02/202412:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
22/02/202412:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202409:28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
17/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
14/02/202408:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RCKTRocket Pharmaceuticals Inc
13/02/202423:00Business WireRocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADIā„¢ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)NASDAQ:RCKTRocket Pharmaceuticals Inc
30/01/202407:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
24/01/202408:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
23/01/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
23/01/202407:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
03/01/202408:01Business WireRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RCKTRocket Pharmaceuticals Inc
14/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RCKTRocket Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RCKT